This roundup of companies reflects Truist's view on those well-positioned to capitalize on the advancements in AI, despite the extended timeline for broader adoption. The report by Truist ...

Truist Securities provided insights into the AI enterprise software market, highlighting several companies poised to benefit ...

Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the ...

Aerospace and Defense is anticipated to achieve mid-teens growth for FY2025, supported by record backlogs at Boeing and Airbus. Defense spending is expected to accelerate amid geopolitical tensions.

Microsoft Corporation MSFT analysts balance the positives and negatives of Azure’s weakness and strength in AI from the ...

Carnival Corporation (LON:CCL) & plc (NYSE:CCL), the world's largest cruise operator, has been charting a course through ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

Meanwhile, Truist analyst Joon Lee has an even higher ... The company expects to tell investors more about its timeline in the middle of 2025. At recent prices, CRISPR Therapeutics sports a ...

Venture Global, Inc. (“Venture Global”) announced today the pricing of its initial public offering of 70,000,000 shares of its Class A common stock, par value $0.01 (“Class A common stock”) at a ...

John McDonald, an analyst at Truist Securities, said in a separate research note that the announcement "seems more about the Pinto retirement than any intent to clarify the timeline or plan for ...

Meanwhile, ionQ Inc's CEO, Peter Chapman, provided an optimistic update on the timeline for delivering ... In related developments, both Truist Securities and BofA Securities reaffirmed a Buy ...

Truist Securities Inc. Good afternoon and welcome to the 2024 fourth-quarter earnings conference call hosted by BNY. (Operator Instructions) Please note that this conference call and webcast will ...